glp 1 drugs eli lilly The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss. Similar to the other GLP-1 weight loss drugs, Foundayo, made by Lilly, was approved for Heart & Vessels Retatrutide is a triple-agonist Quantity:1-Bottle

glp 1 drugs eli lilly The U.S. Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss. Similar to the other GLP-1 weight loss drugs, Foundayo, made by Lilly, was approved for Heart & Vessels Retatrutide is a triple-agonist Quantity:1-Bottle

Retatrutide is a triple-agonist (GLP-1 + GIP + glucagon) and recent clinical trials are showing remarkable outcomes in obesity treatment. 🔬 Latest data highlights: • ~25–30% average body-weight reduction in long-term trials

Employers are also impacted by the financial implications of obesity

Heart & Vessels

Quantity:1-Bottle

LUPKIN: Some just aren't into the idea